InVivoMAb anti-mouse TIM-3 (CD366)

Hsu JM, Xia W, Hsu YH, et al. STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion. Nat Commun. 2018,9(1):1908. doi: 10.1038/s41467-018-04313-6

Wang HW, Zhu XL, Qin LM, et al. Microglia activity modulated by T cell Ig and mucin domain protein 3 (Tim-3). Cell Immunol. 2015,293(1):49-58. doi: 10.1016/j.cellimm.2014.12.005

Hou H, Liu W, Wu S, et al. Tim-3 negatively mediates natural killer cell function in LPS-induced endotoxic shock. PLoS One. 2014,9(10):e110585. doi: 10.1371/journal.pone.0110585

Hongo D, Tang X, Baker J, et al. Requirement for interactions of natural killer T cells and myeloid-derived suppressor cells for transplantation tolerance. Am J Transplant. 2014,14(11):2467-77. doi: 10.1111/ajt.12914

Chabtini L, Mfarrej B, Mounayar M, et al. TIM-3 regulates innate immune cells to induce fetomaternal tolerance. J Immunol. 2013,190(1):88-96. doi: 10.4049/jimmunol.1202176

Hongo D, Tang X, Dutt S, et al. Interactions between NKT cells and Tregs are required for tolerance to combined bone marrow and organ transplants. Blood. 2012,119(6):1581-9. doi: 10.1182/blood-2011-08-371948

Wang F, Wan L, Zhang C, et al. Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. Immunobiology. 2009,214(5):342-9. doi: 10.1016/j.imbio.2008.10.007

Nakae S, Iikura M, Suto H, et al. TIM-1 and TIM-3 enhancement of Th2 cytokine production by mast cells. Blood. 2007,110(7):2565-8.

Frisancho-Kiss S, Nyland JF, Davis SE, et al. Cutting edge: T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity. J Immunol. 2006,176(11):6411-5.

Monney L, Sabatos CA, Gaglia JL, et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature. 2002,415(6871):536-41.